Proteasome regulates turnover of toxic human amylin in pancreatic cells.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Biochemical Journal

• Publication date

  2016-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1042/BCJ20160026PMID 27340132PMCID PMC5056598
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rapid nuclear transit and impaired degradation of amyloid β and glypican-1-derived heparan sulfate in Tg2576 mouse fibroblasts.

  2015cited by this paper
• Autophagy in the physiology and pathology of the central nervous system

  2014cited by this paper
• Paradigms of protein degradation by the proteasome.

  2014cited by this paper
• Autophagy defends pancreatic β cells from human islet amyloid polypeptide-induced toxicity.

  2014cited by this paper
• The mechanism for molecular assembly of the proteasome.

  2014cited by this paper
• UCHL1 deficiency exacerbates human islet amyloid polypeptide toxicity in β-cells

  2014cited by this paper
• Nuclear Translocation Uncovers the Amyloid Peptide Aβ42 as a Regulator of Gene Transcription*♦

  2014cited by this paper
• Chaperones Ameliorate Beta Cell Dysfunction Associated with Human Islet Amyloid Polypeptide Overexpression

  2014cited by this paper
• Targeting Hsp90 and its co-chaperones to treat Alzheimer’s disease

  2014cited by this paper
• Interactions of ataxin-3 with its molecular partners in the protein machinery that sorts protein aggregates to the aggresome.

  2014cited by this paper
• Amyloidogenic peptide oligomer accumulation in autophagy-deficient β cells induces diabetes.

  2014cited by this paper
• Ubiquitin-independent proteasomal degradation.

  2014cited by this paper
• Copper(II)-human amylin complex protects pancreatic cells from amylin toxicity.

  2013cited by this paper
• Protein aggregation and degradation mechanisms in neurodegenerative diseases.

  2013cited by this paper
• Mechanisms for the Insertion of Toxic, Fibril-like β-Amyloid Oligomers into the Membrane.

  2013cited by this paper
• Islet amyloid polypeptide toxicity and membrane interactions

  2013cited by this paper
• Mechanisms of islet amyloidosis toxicity in type 2 diabetes

  2013cited by this paper
• Distinct Internalization Pathways of Human Amylin Monomers and Its Cytotoxic Oligomers in Pancreatic Cells

  2013cited by this paper
• Insulin Resistance and Type 2 Diabetes

  2012cited by this paper
• Degradation of islet amyloid polypeptide by neprilysin

  2012cited by this paper
• Alzheimer Aβ peptide interactions with lipid membranes

  2012cited by this paper
• Concentration‐dependent transitions govern the subcellular localization of islet amyloid polypeptide

  2012cited by this paper
• Human-IAPP disrupts the autophagy/lysosomal pathway in pancreatic β-cells: protective role of p62-positive cytoplasmic inclusions

  2011cited by this paper
• Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.

  2011cited by this paper
• Involvement of mitochondrial dysfunction in human islet amyloid polypeptide-induced apoptosis in INS-1E pancreatic beta cells: An effect attenuated by phycocyanin.

  2011cited by this paper
• Clustering and Internalization of Toxic Amylin Oligomers in Pancreatic Cells Require Plasma Membrane Cholesterol*

  2011cited by this paper
• Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway.

  2010cited by this paper
• The ligand-free state of the TPP riboswitch: a partially folded RNA structure.

  2010cited by this paper
• ATP-dependent steps in the binding of ubiquitin conjugates to the 26S proteasome that commit to degradation.

  2010cited by this paper
• The role of amylin in the control of energy homeostasis.

  2010cited by this paper
• Ubiquitin-independent p53 proteasomal degradation

  2010cited by this paper
• Mitochondria-Targeted Antioxidants Protect Against Amyloid-β Toxicity in Alzheimer's Disease Neurons

  2010cited by this paper
• Effect of Proteasome Inhibitors With Different Chemical Structures on the Ubiquitin–Proteasome System In Vitro

  2010cited by this paper
• Aβ and human amylin share a common toxicity pathway via mitochondrial dysfunction

  2010cited by this paper
• Neprilysin Impedes Islet Amyloid Formation by Inhibition of Fibril Formation Rather Than Peptide Degradation*

  2010cited by this paper
• Translocation and Endocytosis for Cell-penetrating Peptide Internalization

  2009cited by this paper
• Cholesterol regulates assembly of human islet amyloid polypeptide on model membranes.

  2009cited by this paper
• Amyloid aggregation on lipid bilayers and its impact on membrane permeability.

  2009cited by this paper
• Calcium-activated Calpain-2 Is a Mediator of Beta Cell Dysfunction and Apoptosis in Type 2 Diabetes*

  2009cited by this paper
• Proteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination.

  2009cited by this paper
• Spontaneous Diabetes in Hemizygous Human Amylin Transgenic Mice That Developed Neither Islet Amyloid nor Peripheral Insulin Resistance

  2008cited by this paper
• Leptin Does Not Directly Regulate the Pancreatic Hormones Amylin and Pancreatic Polypeptide

  2008cited by this paper
• Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis.

  2008cited by this paper
• The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus.

  2008cited by this paper
• Nano-scale imaging and dynamics of amylin-membrane interactions and its implication in type II diabetes mellitus.

  2008cited by this paper
• Autophagy Induction and Autophagosome Clearance in Neurons: Relationship to Autophagic Pathology in Alzheimer's Disease

  2008cited by this paper
• Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization.

  2007cited by this paper
• Impairment of the Ubiquitin-Proteasome Pathway Is a Downstream Endoplasmic Reticulum Stress Response Induced by Extracellular Human Islet Amyloid Polypeptide and Contributes to Pancreatic β-Cell Apoptosis

  2007cited by this paper
• High Expression Rates of Human Islet Amyloid Polypeptide Induce Endoplasmic Reticulum Stress–Mediated β-Cell Apoptosis, a Characteristic of Humans With Type 2 but Not Type 1 Diabetes

  2007cited by this paper
• Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes

  2007cited by this paper
• Accumulation of Amyloid Precursor Protein in the Mitochondrial Import Channels of Human Alzheimer’s Disease Brain Is Associated with Mitochondrial Dysfunction

  2006cited by this paper
• The aggregation potential of human amylin determines its cytotoxicity towards islet β‐cells

  2006cited by this paper
• The roles of intracellular protein-degradation pathways in neurodegeneration

  2006cited by this paper
• Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP.

  2006cited by this paper
• Amylinergic control of food intake.

  2006cited by this paper
• A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73.

  2005cited by this paper
• Mechanisms of beta-cell death in type 2 diabetes.

  2005cited by this paper
• The Tetanus Neurotoxin‐Sensitive and Insensitive Routes to and from the Plasma Membrane: Fast and Slow Pathways?

  2005cited by this paper
• Mechanisms of β-Cell Death in Type 2 Diabetes

  2005cited by this paper
• Co-Secretion of Aldosterone and Cortisol by an Adrenocortical Carcinoma

  2004cited by this paper
• β-Cells in Type 2 Diabetes: A Loss of Function and Mass

  2004cited by this paper
• Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.

  2004cited by this paper
• Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?

  2004cited by this paper
• α-Synuclein Is Degraded by Both Autophagy and the Proteasome*

  2003cited by this paper
• An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures.

  2003cited by this paper
• Fibrillogenic Amylin Evokes Islet β-Cell Apoptosis through Linked Activation of a Caspase Cascade and JNK1*

  2003cited by this paper
• Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity

  2002cited by this paper
• Cytosolic and nuclear aggregation of the amyloid β-peptide following its expression in the endoplasmic reticulum

  2002cited by this paper
• Expanded polyglutamine stretches form an 'aggresome'.

  2002cited by this paper
• Proteasomal degradation of tau protein

  2002cited by this paper
• Parkin Accumulation in Aggresomes Due to Proteasome Impairment*

  2002cited by this paper
• Poly(ADP-ribose) polymerase cleavage during apoptosis: when and where?

  2001cited by this paper
• ULTRASTRUCTURAL EVIDENCE THAT APOPTOSIS IS THE MECHANISM BY WHICH HUMAN AMYLIN EVOKES DEATH IN RINm5F PANCREATIC ISLET β‐CELLS

  2001cited by this paper
• The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site.

  2001cited by this paper
• The amyloid precursor protein (APP)‐cytoplasmic fragment generated by γ‐secretase is rapidly degraded but distributes partially in a nuclear fraction of neurones in culture

  2001cited by this paper
• Aggregate formation and degradation of overexpressed wild-type and mutant urate oxidase proteins. Quality control of organelle-destined proteins by the endoplasmic reticulum

  2000cited by this paper
• Islet amyloid and type 2 diabetes mellitus.

  2000cited by this paper
• Prolonged exposure of pancreatic beta cells to raised glucose concentrations results in increased cellular content of islet amyloid polypeptide precursors

  1999cited by this paper
• Lactacystin, Proteasome Function, and Cell Fate*

  1998cited by this paper
• Recruitment and the Role of Nuclear Localization in Polyglutamine-mediated Aggregation

  1998cited by this paper
• Novel Insulinoma Cell Lines Produced by Iterative Engineering of GLUT2, Glucokinase, and Human Insulin Expression

  1997cited by this paper
• Mutational and DNA Binding Specificity of the Carcinogen 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline*

  1996cited by this paper
• Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.

  1996cited by this paper
• Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.

  1996cited by this paper
• Importance of the ATP-Ubiquitin-Proteasome Pathway in the Degradation of Soluble and Myofibrillar Proteins in Rabbit Muscle Extracts*

  1996cited by this paper
• Amylin modulates beta-cell glucose sensing via effects on stimulus-secretion coupling.

  1993cited by this paper
• Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes.

  1988cited by this paper

• Activation of the 20S proteasome as a possible strategy to counteract amylin oligomerization in type 2 diabetes.

  2025cites this paper
• Amylin exacerbates tau pathology in the visual cortex of diabetic mice by impairing lysosomal activity

  2025cites this paper
• Bridging Pancreatic Amyloidosis and Neurodegeneration: The Emerging Role of Amylin in Diabetic Dementia

  2025cites this paper
• Biomedical importance of the ubiquitin-proteasome system in diabetes and metabolic transdifferentiation of pancreatic duct epithelial cells into β-cells.

  2023cites this paper
• Pomegranate peel, chokeberry leaves and Ironwort extract as novel natural inhibitors of amylin aggregation and cellular toxicity in pancreatic β cells.

  2023cites this paper
• Molecular Mechanisms of Amylin Turnover, Misfolding and Toxicity in the Pancreas

  2022influential citation
• Convergent Molecular Pathways in Type 2 Diabetes Mellitus and Parkinson’s Disease: Insights into Mechanisms and Pathological Consequences

  2022cites this paper
• Structural basis for the inhibition of IAPP fibril formation by the co-chaperonin prefoldin

  2022cites this paper
• FoxA2 and RNA Pol II Mediate Human Islet Amyloid Polypeptide Turnover in ER-stressed Pancreatic β-cells.

  2021cites this paper
• Proteostasis of Islet Amyloid Polypeptide: A Molecular Perspective of Risk Factors and Protective Strategies for Type II Diabetes.

  2021cites this paper
• Amylin and amylin receptors in Alzheimer's disease

  2020cites this paper
• Protein-conformational diseases in childhood: Naturally-occurring hIAPP amyloid-oligomers and early β-cell damage in obesity and diabetes

  2020cites this paper
• Are Heat Shock Proteins an Important Link between Type 2 Diabetes and Alzheimer Disease?

  2020cites this paper
• Cell assay for the identification of amyloid inhibitors in systemic AA amyloidosis

  2019cites this paper
• Protein aggregates and proteostasis in aging: Amylin and β-cell function.

  2019cites this paper
• Pyrazolones Activate the Proteasome by Gating Mechanisms and Protect Neuronal Cells from β‐Amyloid Toxicity

  2019cites this paper
• Targeting Trafficking in Drug Development

  2018cites this paper
• Apoptosis signal regulating kinase-1 and NADPH oxidase mediate human amylin evoked redox stress and apoptosis in pancreatic beta-cells.

  2018cites this paper
• Functional proteasome complex is required for turnover of islet amyloid polypeptide in pancreatic β-cells

  2018influential citation
• The Molecular Physiopathogenesis of Islet Amyloidosis.

  2018influential citation
• Novel insight into streptozotocin-induced diabetic rats from the protein misfolding perspective

  2017cites this paper